Cancer Treatment Centers of America (CTCA) — Cyborg Score 6/10
Solid
Specialty hospital oncology care and cancer treatment networks
Strategic Profile
Founded in 1988 on a personalized, patient-centered approach to cancer care, CTCA is dedicated to tailoring a combination of cancer treatments to the needs of each individual patient. CTCA is a part of City of Hope, a National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network. As a City of Hope subsidiary, CTCA leverages its parent's research capabilities and clinical expertise while maintaining its specialized oncology focus across multiple states.
Cyborg Score Rationale
CTCA operates a stable, specialized oncology network with established patient-centered care model and geographic presence. However, as a 2022 acquisition, integration and standalone financial data are limited. The parent company (City of Hope) provides scale and research infrastructure, but CTCA's independent operational momentum is not fully transparent.
Top Insights
CTCA operates as City of Hope's national oncology network subsidiary following the February 2022 acquisition, providing geographic expansion and a dedicated cancer care brand
The network shifted from for-profit to non-profit status and rebranding in 2023, aligning with City of Hope's research and comprehensive cancer care mission
Parent company City of Hope reported over $7.2 billion in total assets and over $3 billion in total revenues as of 2023, providing substantial financial backing
CTCA maintains a specialized, patient-centered approach with multi-disciplinary team-based oncology care model differentiating it from general health systems
Named Competitors
MD Anderson Cancer Center — Comprehensive academic cancer center with research and clinical services
Mayo Clinic Cancer Care — Multi-state integrated health system with comprehensive oncology services
Sloan Kettering Memorial — Specialized independent cancer center with integrated patient care
Cigna Health Services — Health insurance and integrated care provider covering oncology services
Recent Developments
(February 2022) City of Hope completed acquisition of CTCA for reported $390 million
(2023) CTCA rebranded under City of Hope name; facilities transitioned to non-profit status; all locations renamed as 'City of Hope [City]'
(2023) Integration of CTCA leadership with City of Hope structure; Pat Basu retained as CTCA president and CEO reporting to City of Hope leadership
Open the full interactive Cancer Treatment Centers of America (CTCA) report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.